NeuroBo Pharmaceuticals Stock (NASDAQ: NRBO) stock price, news, charts, stock research, profile.
You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ:NRBO) through any online brokerage.
Other companies in NeuroBo Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Acurx Pharmaceuticals (NASDAQ:ACXP), Monopar Therapeutics (NASDAQ:MNPR), Lumos Pharma (NASDAQ:LUMO) and Aligos Therapeutics (NASDAQ:ALGS).
NeuroBo Pharmaceuticals has a consensus price target of $8.00.
The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $2.9 last updated October 1, 2024 at 6:18 PM EDT.
There are no upcoming dividends for NeuroBo Pharmaceuticals.
NeuroBo Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for NeuroBo Pharmaceuticals.
NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.